Heartbeam Inc (BEAT:NASDAQ) Investor Relations Material

Overview

California-based medical technology firm, HeartBeam, Inc., is making waves in the cardiology sector, with its primary focus on the development and commercialization of ambulatory electrocardiogram solutions for detecting and monitoring cardiac disease in hospital and private settings. With its cutting-edge technology, the company creates three-dimensional vector images of cardiac electrical activity to enable accurate diagnostic insights. Among its impressive suite of products, HeartBeam AIMIGo is a remarkable credit card-sized, cloud-based diagnostic software system specially designed for detecting heart attacks. Founded in 2015, the company is set to continue making strides in revolutionizing the healthcare industry.

Frequently Asked Questions

What is Heartbeam Inc's ticker?

Heartbeam Inc's ticker is BEAT

What exchange is Heartbeam Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Heartbeam Inc's headquarters?

They are based in Malvern, Pennsylvania

How many employees does Heartbeam Inc have?

There are 1001-5000 employees working at Heartbeam Inc

What is Heartbeam Inc's website?

It is heartbeam.com

What type of sector is Heartbeam Inc?

Heartbeam Inc is in the Healthcare sector

What type of industry is Heartbeam Inc?

Heartbeam Inc is in the Medical Laboratories & Research industry

Who are Heartbeam Inc's peers and competitors?

The following five companies are Heartbeam Inc's industry peers:

- PRA Health Sciences Inc

- QRxPharma Limited

- Laboratory Corporation of America

- Cytosorbents

- Bruker